StageSeries B | Alive
Last Raised$10.91M | 14 days ago
Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+170 points in the past 30 days
About C4U Corporation
C4U develops CRISPR-Cas3 technology using genome editing technology. It focuses on genetic diseases and new treatments for various diseases by treatment using genetically modified cells. The company was founded in 2018 and is based in Suita, Japan.
Missing: C4U Corporation's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: C4U Corporation's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
C4U Corporation Patents
C4U Corporation has filed 1 patent.
The 3 most popular patent topics include:
C4U Corporation Frequently Asked Questions (FAQ)
When was C4U Corporation founded?
C4U Corporation was founded in 2018.
Where is C4U Corporation's headquarters?
C4U Corporation's headquarters is located at 2-8 Yamadaoka, Suita.
What is C4U Corporation's latest funding round?
C4U Corporation's latest funding round is Series B.
How much did C4U Corporation raise?
C4U Corporation raised a total of $20.85M.
Who are the investors of C4U Corporation?
Investors of C4U Corporation include DCI Partners, Nissay Capital, Mizuho Financial Group, Japan Science and Technology Agency, Mitsubishi UFJ Capital and 11 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.